Published in Gene Therapy Weekly, January 20th, 2000
Gary J. Nable presented updated data regarding progress being made in gene therapy for cancer at the conference Gene Therapy, Delivering the Medicines of the 21st Century, held November 7-9, 1999, in Washington, DC. The title of his presentation was "Fas Ligand (CD95L) and Cancer Gene Therapy."
"Recent progress in understanding the genetic basis for human cancer has led to a variety of new perspectives regarding the pathogenesis of this disease," wrote Nabel, who was representing colleagues...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.